Healthcare & Education
3i exits eyecare provider Nexeye to KKR
The buyer is acquiring the business primarily through its $8bn European Fund VI
BC Partners partially exits pharma CDMO Aenova Group in trade sale
BC Partners acquired the company from Bridgepoint in 2012
Trill Impact backs Austria-based TT medic
The portfolio company was established through the combination of three DACH family-owned businesses
KKR invests in Impilo-backed Immedica Pharma
Existing owner Impilo will reinvest to become an equal owner alongside KKR
Apax-backed Palex Medical forms European medtech platform with new add-on
Apax first invested in Palex in July 2023
All Seas Capital invests in Reducate EdTech Group
The deal marks the GP's first investment in the Netherlands
Genesis Capital’s first growth equity fund marks inaugural exit
The GP first invested in Homecare Holding in 2020
Lakestar closes latest fund generation on $600m
Lakestar Early IV and Lakestar Growth II will focus their investments in AI, digitalisation, deeptech, healthcare and fintech
Fund in Focus: Manulife Strategic Secondaries Fund closes on more than €550m
The fund focuses on GP-led secondaries and has already commenced its deployment phase, global head of co-secondaries Jeff Hammer tells Real Deals
Miura Partners extends holding of dental business Proclinic Group
The Spanish GP has raised a single-asset continuation vehicle
Inflexion-backed CNX Therapeutics acquires two medicines
The portfolio company was originally formed in August 2021 when Inflexion acquired Sunovion Pharmaceuticals Europe
Mentha sells Paradigma Group to Castik Capital
The portfolio company’s founder and management team will remain shareholders in the business
Nexxus Iberia PE II holds final closing on €241m
Iberian SMEs and sustainability are in the fund’s sights
ThinCats launches regional fund
The fund targets midsized SMEs across the UK
Montagu carves out Johnson Matthey’s MDC
Johnson Matthey is a multinational speciality chemicals company listed on the FTSE250
Endless exits Findel investment to Manutan
The seller originally acquired Findel in 2021 from Studio Retail Group
Kester Capital III closes on £200m hard-cap
The fund is more than double the size of its predecessor
Gilde Healthcare sells RAD-x stake to infra consortium
The buy-side comprises Swiss Life Asset Managers' and Vesper Infrastructure Partners’ infrastructure platforms
Pricoa picks up minority stake in TeacherActive
The portco has been supported by Tosca Debt Capital since 2018
Sherpa sells Horizons Optical
Sherpa acquired the business in 2017 through its Fund II
EQT sells stake in Ottobock
The transaction is set to value the prosthetics firm at €5.5bn
Keensight-backed BYG4lab acquires Finbiosoft
The deal expands BYG4lab’s footprint in new markets
Kurma Partners sells Amolyt Pharma
The deal marks the third major exit of Kurma Biofund III and the first exit of Kurma Growth Opportunities Fund
Asabys Partners exits Cara Care in trade sale
San Francisco-based Mahana Therapeutics, which has bought the business, provides digital chronic condition management programmes
Schroders Capital launches UK LTAF
The fund eyes tech and science opportunities within the UK VC arena
Foresight sells Specac
The business’s revenues grew five-fold during the holding period
Cibus Capital harvests over $600m for food and agriculture investments
The GP believes agrifood technology has the potential for "unprecedented positive change"
EMZ Partners-backed portco expands to the US
The GP’s portfolio company FotoFinder Systems has acquired DermLite
Gilde Healthcare co-leads series-B round in Arga MedTech
Advent Life Sciences and Earlybird Venture Capital also invested in the round
British Patient Capital invests in Curve Therapeutics
The deal was part of the firm’s series-A round
Palatine’s maiden Growth Credit Fund holds first close
The fund will support maturing, high-growth but not startup companies
Motion Equity Partners acquires Axience Group
The French company develops pharmaceuticals for pets
Gilde Healthcare leads financing in Mainstay Medical
The financing round also included new backer Viking Global Investors
Palatine-backed B2W Group targets green energy growth
The transaction represents the third bolt-on for the training company under Palatine
GP Profile: Arca Space Capital
CEO Ugo Loeser tells Real Deals the PE fund is currently assessing two new deals
Nord Holding acquires ABJ Alive
The company is eyeing growth via expansion of its capacity, products and services
GP Profile: Perwyn
Managing partner Andrew Wynn speaks to Real Deals about what makes the perfect deal and the firm's new office in Milan
BaltCap sells Karell Kiirabi
The original transaction in 2019 marked BaltCap’s maiden investment in Estonia
August Equity exits Agilio Software
The firm was sold to Five Arrows and TA Associates
CAPZA and BPI France back IMDEV
CAPZA invested through its Flex Equity Mid-Market II fund
Miura Partners sells Terrats Medical to Avista Capital
Terrats sells to 50-plus countries
Fund in Focus: Epiris Fund III holds final close on £1.044bn
Alex Cooper-Evans, partner, tells Real Deals the fund had strong re-ups from existing LPs
NorthEdge-backed Helios bolts on Cogentia
The business has grown its headcount from 100 to 250 under the GP’s leadership
Bregal-backed Italgel Group bolts on Protein
It is the first acquisition by Italgel since Bregal first invested in 2022
Fund in Focus: Fondo Italiano d’Investimento’s co-investment fund hits first close on €82m
Roberto Travaglino tells Real Deals that the investor hopes to reach its final close within 12 months
Mérieux Equity Partners acquires InnoSyn
The deal represents the ninth transaction by MP4 and its first in the Netherlands
FPE-backed Egress Group acquires Stalis
The UK-based company provides specialist IT consultancy services and bespoke solutions to the healthcare sector
BGF-backed BN Care bolts on Devon care home
The GP first invested £3.4m in the business in February 2023
Abris-backed Scanmed bolts on Polish healthcare firm
The deal represents the third acquisition since Abris first invested in the business
Maven invests in medtech business Carcinotech
The British Business Bank has inked its first major deal from its £150m Investment Fund for Scotland through appointed fund manager Maven Capital Partners
AIB Foresight SME Impact Fund holds second closing
The fund received a cornerstone commitment from AIB in 2022
Progressio Investimenti IV holds first closing on €182m
Commitments from its existing investor base made up more than 75% of the fundraising, the GP said
Exponent nears Chanelle Pharm acquisition
The UK GP is currently investing from its fourth fund
Exclusive: Arcano Partners eyes Q1 first close for second impact fund
The firms aims to secure commitments from its existing backers before expanding its outreach to international investors, Ricardo Miró-Quesada tells Real Deals
Main Capital acquires majority stake in Buchner
The portfolio company's management team has retained a minority stake
N4 Partners makes additional investment in NeuroClin
Foresight Group and Fullbrook Thorpe Investments are also investors in the research business
CVC invests in Sunday Natural
The GP will support the business’s international scaling
Extens acquires Imagine Human
The investment firm will focus on organic and inorganic growth in France and Europe
Fund in Focus: How Cinven banked $14.5bn for Fund 8
Real Deals catches up with Alexandra Hess, partner and head of investor relations, to discuss how the GP overcame a difficult macro environment to reach the fund’s hard-cap
Limerston carves out stability storage business
The newly created standalone entity will be called Astoriom
ScaleUp sells edtech business
The acquisition has been completed by a local family office in collaboration with the management team
Ambienta buys majority stake in educational technology business
The deal marks the GP’s second edtech platform investment in the last 12 months
H2 Equity Partners sells medical device firm
The GP first invested in the business in 2015
H2 Equity Partners backs UK-based medical equipment distributor
The GP is currently investing from its £300m Fund VI
IK and MxEP exit Mabtech stakes to EQT
The deal marks the buyer’s first investment from its EQT Healthcare Growth strategy
Main Capital Partners-backed BCS HR Software acquires SaaS firm
The deal marks the sixth acquisition since the GP first invested in 2022
Cinven closes flagship fund at $14.5bn
Fund 8 is nearly 30% larger than its predecessor
Deal in Focus: Eurazeo exits €1bn ophthalmology platform
Francesco Orsi of Eurazeo sits down with Real Deals to discuss the GP’s value creation strategy, which included a new product launch and expansion into China
Gilde Healthcare exits biotech firm
The GP has sold Calypso Biotech to Novartis
Stuart Quin joins GHO Capital as partner
Quin has nearly two decades of experience in private equity
Queen’s Park Equity-backed Learndirect completes sixth bolt-on
The add-on increases Learndirect’s presence in the B2B space
Jeito Capital promotes new partner investor
Ksenija Pavletic brings more than 25 years of healthcare expertise to her new role
GHO-backed Sanner Group bolts on Springboard Pro
The GP first invested in the German packaging solutions supplier in 2021
PAI Partners exits diagnostics manufacturer
ELITech was sold to Bunker Corporations
Horizon Capital-backed Modern Networks bolts on Wave9
The deal will see the IT provider venturing into the education segment
Gilde Healthcare acquires majority stake in Swiss Dental Solutions
The portfolio company will look to accelerate growth in the US and Europe
Fund in Focus: Foresight seeks SME opps for two new funds
The GP remains sector agnostic and has ticket sizes of up to £10m, partner Matt Smith tells Real Deals
Fund in Focus: Revaia Fund II holds first close on €150m
Fund II has already invested in three firms, Alice Albizzati tells Real Deals
Stirling Square exits OFG
TPG and Investcorp have acquired stakes in the portco
Pictet raises $320m for health PE fund
The alternative investment business exceeded its target size
Siparex-led consortium exits Nowak industrial group
The company’s turnover has increased by 76% in five years
Fortino Capital’s second PE fund holds final close on €377m
The GP seeks to invest in B2B SaaS and PaaS firms with at least €5m turnover
Venture Views: Emma Ventures completes first lead investment
Real Deals speaks with co-founders Christian Diller and Katja Baur to learn how diversity is integral to the VC firm’s ethos
Nexxus Iberia’s second vintage begins deployment
While the GP is sector-agnostic, it favours healthcare opportunities in Iberia, co-founder Pablo Gallo reveals to Real Deals
Impilo-backed Scantox bolts on QPS Neuro
The bolt-on will increase the firm’s service offering
Mérieux Equity acquires majority in Labquality
The deal was made from the GP’s latest investment vehicle Mérieux Participations 4
Fremman acquires HT Médica
The deal is the GP’s sixth overall platform investment
Tresmares acquires minority stake in Exam Papers Plus
Tresmares will become the lead institutional investor in the business, Miguel Sanchez, investment director, told Real Deals
Motion Equity Partners-backed EA Pharma bolts on Group W
The food specialist continues its international expansion with its seventh bolt-on
Abris-backed Scanmed bolts on Med-Lux
The Poland-based GP acquired Scanmed in 2020
BGF sells Antser Group in YFM-backed MBO
BGF invested £8.5m in Antser Group in September 2021
NorthEdge invests in Torbay Pharmaceuticals
This is the GP’s seventh healthcare investment
Gilde Healthcare picks up surgical instruments manufacturer
The GP will merge Koscher & Würtz with a portfolio company
IW Capital invests in Plumm
The GP seeks to bolster Plumm’s international presence
Archimed acquires two dermatological specialists
The GP has merged Symbio and Proinnovera to create Symbio Proinnovera
Jeito Capital leads €75m investment in NMD Pharma
The new funds will support the firm’s expansion in Denmark and the US
Gilde’s fourth venture and growth fund holds final close on €740m hard-cap
The vehicle held a first close at €600m in April this year
Permira acquires pharmaceutical services firm Ergomed
The GP’s pharma portfolio companies include Cambrex, Quotient Services and Neuraxpharm
Apposite Capital-backed Kelso Pharma initiates European expansion
The company has acquired Italy-based Velit Biopharma
Foresight nets 3.2x return on ONFAB stake sale
This is the seventh exit from Foresight’s Regional Investment Fund